Cis Biotech, Inc.
Records under this name other than patents Cis Biotech, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Cis Biotech, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,084,225 | Methods for diagnosing cerebrovascular events based on NR2 peptides Lapsed on the fee record Ended Dec 27, 2019 · From the USPTO record | Lapsed on the fee record | Ended Dec 27, 2019 | From the USPTO record |
| US 7,658,911 | Antibody assay methods to assess risk for TIA/stroke Lapsed on the fee record Ended Feb 9, 2018 · From the USPTO record | Lapsed on the fee record | Ended Feb 9, 2018 | From the USPTO record |
| US 7,622,100 | Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke Lapsed on the fee record Ended Nov 24, 2017 · From the USPTO record | Lapsed on the fee record | Ended Nov 24, 2017 | From the USPTO record |
| US 7,622,114 | Assay methods for immediate diagnosis of cause of stroke Lapsed on the fee record Ended Nov 24, 2017 · From the USPTO record | Lapsed on the fee record | Ended Nov 24, 2017 | From the USPTO record |
| US 6,896,872 | Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke Lapsed on the fee record Ended May 24, 2017 · From the USPTO record | Lapsed on the fee record | Ended May 24, 2017 | From the USPTO record |